Global Bacterial Vaccines Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Bacterial Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bacterial Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Bacterial Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsular Polysaccharide Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Bacterial Vaccines include Pfizer, Merck, GlaxoSmithKline, Sanofi, and PaxVax, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bacterial Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Bacterial Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Bacterial Vaccines, with revenue, gross margin and global market share of Bacterial Vaccines from 2019 to 2022.
Chapter 3, the Bacterial Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Bacterial Vaccines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Bacterial Vaccines research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Bacterial Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Bacterial Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Capsular Polysaccharide Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Bacterial Vaccines include Pfizer, Merck, GlaxoSmithKline, Sanofi, and PaxVax, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Bacterial Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Capsular Polysaccharide Vaccines
- Toxoid Vaccines
- Purified Protein Vaccines
- Live Attenuated Bacterial Vaccines
- Killed Bacterial Vaccines
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Pfizer
- Merck
- GlaxoSmithKline
- Sanofi
- PaxVax
- Serum Institute of India
- Emergent BioDefense Operations Lansing
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Bacterial Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Bacterial Vaccines, with revenue, gross margin and global market share of Bacterial Vaccines from 2019 to 2022.
Chapter 3, the Bacterial Vaccines competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Bacterial Vaccines market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Bacterial Vaccines research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Bacterial Vaccines
1.2 Classification of Bacterial Vaccines by Type
1.2.1 Overview: Global Bacterial Vaccines Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Bacterial Vaccines Revenue Market Share by Type in 2021
1.2.3 Capsular Polysaccharide Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Purified Protein Vaccines
1.2.6 Live Attenuated Bacterial Vaccines
1.2.7 Killed Bacterial Vaccines
1.2.8 Others
1.3 Global Bacterial Vaccines Market by Application
1.3.1 Overview: Global Bacterial Vaccines Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bacterial Vaccines Market Size & Forecast
1.5 Global Bacterial Vaccines Market Size and Forecast by Region
1.5.1 Global Bacterial Vaccines Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Bacterial Vaccines Market Size by Region, (2017-2022)
1.5.3 North America Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.4 Europe Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.6 South America Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Bacterial Vaccines Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacterial Vaccines Market Drivers
1.6.2 Bacterial Vaccines Market Restraints
1.6.3 Bacterial Vaccines Trends Analysis
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bacterial Vaccines Product and Solutions
2.1.4 Pfizer Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Bacterial Vaccines Product and Solutions
2.2.4 Merck Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Bacterial Vaccines Product and Solutions
2.3.4 GlaxoSmithKline Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Bacterial Vaccines Product and Solutions
2.4.4 Sanofi Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 PaxVax
2.5.1 PaxVax Details
2.5.2 PaxVax Major Business
2.5.3 PaxVax Bacterial Vaccines Product and Solutions
2.5.4 PaxVax Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 PaxVax Recent Developments and Future Plans
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Bacterial Vaccines Product and Solutions
2.6.4 Serum Institute of India Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Serum Institute of India Recent Developments and Future Plans
2.7 Emergent BioDefense Operations Lansing
2.7.1 Emergent BioDefense Operations Lansing Details
2.7.2 Emergent BioDefense Operations Lansing Major Business
2.7.3 Emergent BioDefense Operations Lansing Bacterial Vaccines Product and Solutions
2.7.4 Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Emergent BioDefense Operations Lansing Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Bacterial Vaccines Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Bacterial Vaccines Players Market Share in 2021
3.2.2 Top 10 Bacterial Vaccines Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Bacterial Vaccines Players Head Office, Products and Services Provided
3.4 Bacterial Vaccines Mergers & Acquisitions
3.5 Bacterial Vaccines New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Bacterial Vaccines Revenue and Market Share by Type (2017-2022)
4.2 Global Bacterial Vaccines Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Bacterial Vaccines Revenue Market Share by Application (2017-2022)
5.2 Global Bacterial Vaccines Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Bacterial Vaccines Revenue by Type (2017-2028)
6.2 North America Bacterial Vaccines Revenue by Application (2017-2028)
6.3 North America Bacterial Vaccines Market Size by Country
6.3.1 North America Bacterial Vaccines Revenue by Country (2017-2028)
6.3.2 United States Bacterial Vaccines Market Size and Forecast (2017-2028)
6.3.3 Canada Bacterial Vaccines Market Size and Forecast (2017-2028)
6.3.4 Mexico Bacterial Vaccines Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Bacterial Vaccines Revenue by Type (2017-2028)
7.2 Europe Bacterial Vaccines Revenue by Application (2017-2028)
7.3 Europe Bacterial Vaccines Market Size by Country
7.3.1 Europe Bacterial Vaccines Revenue by Country (2017-2028)
7.3.2 Germany Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.3 France Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.5 Russia Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.6 Italy Bacterial Vaccines Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Bacterial Vaccines Revenue by Type (2017-2028)
8.2 Asia-Pacific Bacterial Vaccines Revenue by Application (2017-2028)
8.3 Asia-Pacific Bacterial Vaccines Market Size by Region
8.3.1 Asia-Pacific Bacterial Vaccines Revenue by Region (2017-2028)
8.3.2 China Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.3 Japan Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.4 South Korea Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.5 India Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.7 Australia Bacterial Vaccines Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Bacterial Vaccines Revenue by Type (2017-2028)
9.2 South America Bacterial Vaccines Revenue by Application (2017-2028)
9.3 South America Bacterial Vaccines Market Size by Country
9.3.1 South America Bacterial Vaccines Revenue by Country (2017-2028)
9.3.2 Brazil Bacterial Vaccines Market Size and Forecast (2017-2028)
9.3.3 Argentina Bacterial Vaccines Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Bacterial Vaccines Revenue by Type (2017-2028)
10.2 Middle East & Africa Bacterial Vaccines Revenue by Application (2017-2028)
10.3 Middle East & Africa Bacterial Vaccines Market Size by Country
10.3.1 Middle East & Africa Bacterial Vaccines Revenue by Country (2017-2028)
10.3.2 Turkey Bacterial Vaccines Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Bacterial Vaccines Market Size and Forecast (2017-2028)
10.3.4 UAE Bacterial Vaccines Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Bacterial Vaccines
1.2 Classification of Bacterial Vaccines by Type
1.2.1 Overview: Global Bacterial Vaccines Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Bacterial Vaccines Revenue Market Share by Type in 2021
1.2.3 Capsular Polysaccharide Vaccines
1.2.4 Toxoid Vaccines
1.2.5 Purified Protein Vaccines
1.2.6 Live Attenuated Bacterial Vaccines
1.2.7 Killed Bacterial Vaccines
1.2.8 Others
1.3 Global Bacterial Vaccines Market by Application
1.3.1 Overview: Global Bacterial Vaccines Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bacterial Vaccines Market Size & Forecast
1.5 Global Bacterial Vaccines Market Size and Forecast by Region
1.5.1 Global Bacterial Vaccines Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Bacterial Vaccines Market Size by Region, (2017-2022)
1.5.3 North America Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.4 Europe Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.6 South America Bacterial Vaccines Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Bacterial Vaccines Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Bacterial Vaccines Market Drivers
1.6.2 Bacterial Vaccines Market Restraints
1.6.3 Bacterial Vaccines Trends Analysis
2 COMPANY PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Bacterial Vaccines Product and Solutions
2.1.4 Pfizer Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Bacterial Vaccines Product and Solutions
2.2.4 Merck Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Merck Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Bacterial Vaccines Product and Solutions
2.3.4 GlaxoSmithKline Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Bacterial Vaccines Product and Solutions
2.4.4 Sanofi Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 PaxVax
2.5.1 PaxVax Details
2.5.2 PaxVax Major Business
2.5.3 PaxVax Bacterial Vaccines Product and Solutions
2.5.4 PaxVax Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 PaxVax Recent Developments and Future Plans
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Bacterial Vaccines Product and Solutions
2.6.4 Serum Institute of India Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Serum Institute of India Recent Developments and Future Plans
2.7 Emergent BioDefense Operations Lansing
2.7.1 Emergent BioDefense Operations Lansing Details
2.7.2 Emergent BioDefense Operations Lansing Major Business
2.7.3 Emergent BioDefense Operations Lansing Bacterial Vaccines Product and Solutions
2.7.4 Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Emergent BioDefense Operations Lansing Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Bacterial Vaccines Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Bacterial Vaccines Players Market Share in 2021
3.2.2 Top 10 Bacterial Vaccines Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Bacterial Vaccines Players Head Office, Products and Services Provided
3.4 Bacterial Vaccines Mergers & Acquisitions
3.5 Bacterial Vaccines New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Bacterial Vaccines Revenue and Market Share by Type (2017-2022)
4.2 Global Bacterial Vaccines Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Bacterial Vaccines Revenue Market Share by Application (2017-2022)
5.2 Global Bacterial Vaccines Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Bacterial Vaccines Revenue by Type (2017-2028)
6.2 North America Bacterial Vaccines Revenue by Application (2017-2028)
6.3 North America Bacterial Vaccines Market Size by Country
6.3.1 North America Bacterial Vaccines Revenue by Country (2017-2028)
6.3.2 United States Bacterial Vaccines Market Size and Forecast (2017-2028)
6.3.3 Canada Bacterial Vaccines Market Size and Forecast (2017-2028)
6.3.4 Mexico Bacterial Vaccines Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Bacterial Vaccines Revenue by Type (2017-2028)
7.2 Europe Bacterial Vaccines Revenue by Application (2017-2028)
7.3 Europe Bacterial Vaccines Market Size by Country
7.3.1 Europe Bacterial Vaccines Revenue by Country (2017-2028)
7.3.2 Germany Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.3 France Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.5 Russia Bacterial Vaccines Market Size and Forecast (2017-2028)
7.3.6 Italy Bacterial Vaccines Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Bacterial Vaccines Revenue by Type (2017-2028)
8.2 Asia-Pacific Bacterial Vaccines Revenue by Application (2017-2028)
8.3 Asia-Pacific Bacterial Vaccines Market Size by Region
8.3.1 Asia-Pacific Bacterial Vaccines Revenue by Region (2017-2028)
8.3.2 China Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.3 Japan Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.4 South Korea Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.5 India Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Bacterial Vaccines Market Size and Forecast (2017-2028)
8.3.7 Australia Bacterial Vaccines Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Bacterial Vaccines Revenue by Type (2017-2028)
9.2 South America Bacterial Vaccines Revenue by Application (2017-2028)
9.3 South America Bacterial Vaccines Market Size by Country
9.3.1 South America Bacterial Vaccines Revenue by Country (2017-2028)
9.3.2 Brazil Bacterial Vaccines Market Size and Forecast (2017-2028)
9.3.3 Argentina Bacterial Vaccines Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Bacterial Vaccines Revenue by Type (2017-2028)
10.2 Middle East & Africa Bacterial Vaccines Revenue by Application (2017-2028)
10.3 Middle East & Africa Bacterial Vaccines Market Size by Country
10.3.1 Middle East & Africa Bacterial Vaccines Revenue by Country (2017-2028)
10.3.2 Turkey Bacterial Vaccines Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Bacterial Vaccines Market Size and Forecast (2017-2028)
10.3.4 UAE Bacterial Vaccines Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Bacterial Vaccines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Bacterial Vaccines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Bacterial Vaccines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Bacterial Vaccines Revenue (USD Million) by Region (2017-2022)
Table 5. Global Bacterial Vaccines Revenue Market Share by Region (2023-2028)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Bacterial Vaccines Product and Solutions
Table 9. Pfizer Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Bacterial Vaccines Product and Solutions
Table 13. Merck Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Bacterial Vaccines Product and Solutions
Table 17. GlaxoSmithKline Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Bacterial Vaccines Product and Solutions
Table 21. Sanofi Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. PaxVax Corporate Information, Head Office, and Major Competitors
Table 23. PaxVax Major Business
Table 24. PaxVax Bacterial Vaccines Product and Solutions
Table 25. PaxVax Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Serum Institute of India Corporate Information, Head Office, and Major Competitors
Table 27. Serum Institute of India Major Business
Table 28. Serum Institute of India Bacterial Vaccines Product and Solutions
Table 29. Serum Institute of India Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Emergent BioDefense Operations Lansing Corporate Information, Head Office, and Major Competitors
Table 31. Emergent BioDefense Operations Lansing Major Business
Table 32. Emergent BioDefense Operations Lansing Bacterial Vaccines Product and Solutions
Table 33. Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Global Bacterial Vaccines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 35. Global Bacterial Vaccines Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 36. Breakdown of Bacterial Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Bacterial Vaccines Players Head Office, Products and Services Provided
Table 38. Bacterial Vaccines Mergers & Acquisitions in the Past Five Years
Table 39. Bacterial Vaccines New Entrants and Expansion Plans
Table 40. Global Bacterial Vaccines Revenue (USD Million) by Type (2017-2022)
Table 41. Global Bacterial Vaccines Revenue Share by Type (2017-2022)
Table 42. Global Bacterial Vaccines Revenue Forecast by Type (2023-2028)
Table 43. Global Bacterial Vaccines Revenue by Application (2017-2022)
Table 44. Global Bacterial Vaccines Revenue Forecast by Application (2023-2028)
Table 45. North America Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 46. North America Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 47. North America Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 48. North America Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 49. North America Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 50. North America Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 51. Europe Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 52. Europe Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 53. Europe Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 54. Europe Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 55. Europe Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 56. Europe Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 57. Asia-Pacific Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 58. Asia-Pacific Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 59. Asia-Pacific Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 60. Asia-Pacific Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 61. Asia-Pacific Bacterial Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 62. Asia-Pacific Bacterial Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 63. South America Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 64. South America Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 65. South America Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 66. South America Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 67. South America Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 68. South America Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 69. Middle East & Africa Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 70. Middle East & Africa Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 71. Middle East & Africa Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 72. Middle East & Africa Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 73. Middle East & Africa Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 74. Middle East & Africa Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Bacterial Vaccines Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Bacterial Vaccines Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Bacterial Vaccines Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Bacterial Vaccines Revenue (USD Million) by Region (2017-2022)
Table 5. Global Bacterial Vaccines Revenue Market Share by Region (2023-2028)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Bacterial Vaccines Product and Solutions
Table 9. Pfizer Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Merck Corporate Information, Head Office, and Major Competitors
Table 11. Merck Major Business
Table 12. Merck Bacterial Vaccines Product and Solutions
Table 13. Merck Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Bacterial Vaccines Product and Solutions
Table 17. GlaxoSmithKline Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Bacterial Vaccines Product and Solutions
Table 21. Sanofi Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. PaxVax Corporate Information, Head Office, and Major Competitors
Table 23. PaxVax Major Business
Table 24. PaxVax Bacterial Vaccines Product and Solutions
Table 25. PaxVax Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Serum Institute of India Corporate Information, Head Office, and Major Competitors
Table 27. Serum Institute of India Major Business
Table 28. Serum Institute of India Bacterial Vaccines Product and Solutions
Table 29. Serum Institute of India Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Emergent BioDefense Operations Lansing Corporate Information, Head Office, and Major Competitors
Table 31. Emergent BioDefense Operations Lansing Major Business
Table 32. Emergent BioDefense Operations Lansing Bacterial Vaccines Product and Solutions
Table 33. Emergent BioDefense Operations Lansing Bacterial Vaccines Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Global Bacterial Vaccines Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 35. Global Bacterial Vaccines Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 36. Breakdown of Bacterial Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Bacterial Vaccines Players Head Office, Products and Services Provided
Table 38. Bacterial Vaccines Mergers & Acquisitions in the Past Five Years
Table 39. Bacterial Vaccines New Entrants and Expansion Plans
Table 40. Global Bacterial Vaccines Revenue (USD Million) by Type (2017-2022)
Table 41. Global Bacterial Vaccines Revenue Share by Type (2017-2022)
Table 42. Global Bacterial Vaccines Revenue Forecast by Type (2023-2028)
Table 43. Global Bacterial Vaccines Revenue by Application (2017-2022)
Table 44. Global Bacterial Vaccines Revenue Forecast by Application (2023-2028)
Table 45. North America Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 46. North America Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 47. North America Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 48. North America Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 49. North America Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 50. North America Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 51. Europe Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 52. Europe Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 53. Europe Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 54. Europe Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 55. Europe Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 56. Europe Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 57. Asia-Pacific Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 58. Asia-Pacific Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 59. Asia-Pacific Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 60. Asia-Pacific Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 61. Asia-Pacific Bacterial Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 62. Asia-Pacific Bacterial Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 63. South America Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 64. South America Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 65. South America Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 66. South America Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 67. South America Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 68. South America Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 69. Middle East & Africa Bacterial Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 70. Middle East & Africa Bacterial Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 71. Middle East & Africa Bacterial Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 72. Middle East & Africa Bacterial Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 73. Middle East & Africa Bacterial Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 74. Middle East & Africa Bacterial Vaccines Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Bacterial Vaccines Picture
Figure 2. Global Bacterial Vaccines Revenue Market Share by Type in 2021
Figure 3. Capsular Polysaccharide Vaccines
Figure 4. Toxoid Vaccines
Figure 5. Purified Protein Vaccines
Figure 6. Live Attenuated Bacterial Vaccines
Figure 7. Killed Bacterial Vaccines
Figure 8. Others
Figure 9. Bacterial Vaccines Revenue Market Share by Application in 2021
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Global Bacterial Vaccines Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Bacterial Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Bacterial Vaccines Revenue Market Share by Region (2017-2028)
Figure 16. Global Bacterial Vaccines Revenue Market Share by Region in 2021
Figure 17. North America Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Bacterial Vaccines Market Drivers
Figure 23. Bacterial Vaccines Market Restraints
Figure 24. Bacterial Vaccines Market Trends
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. PaxVax Recent Developments and Future Plans
Figure 30. Serum Institute of India Recent Developments and Future Plans
Figure 31. Emergent BioDefense Operations Lansing Recent Developments and Future Plans
Figure 32. Global Bacterial Vaccines Revenue Share by Players in 2021
Figure 33. Bacterial Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Bacterial Vaccines Revenue Market Share in 2021
Figure 35. Global Top 10 Players Bacterial Vaccines Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Bacterial Vaccines Revenue Share by Type in 2021
Figure 38. Global Bacterial Vaccines Market Share Forecast by Type (2023-2028)
Figure 39. Global Bacterial Vaccines Revenue Share by Application in 2021
Figure 40. Global Bacterial Vaccines Market Share Forecast by Application (2023-2028)
Figure 41. North America Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 42. North America Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 43. North America Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 44. United States Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 48. Europe Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 49. Europe Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 50. Germany Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Bacterial Vaccines Revenue Market Share by Region (2017-2028)
Figure 58. China Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 65. South America Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 66. South America Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Bacterial Vaccines Picture
Figure 2. Global Bacterial Vaccines Revenue Market Share by Type in 2021
Figure 3. Capsular Polysaccharide Vaccines
Figure 4. Toxoid Vaccines
Figure 5. Purified Protein Vaccines
Figure 6. Live Attenuated Bacterial Vaccines
Figure 7. Killed Bacterial Vaccines
Figure 8. Others
Figure 9. Bacterial Vaccines Revenue Market Share by Application in 2021
Figure 10. Hospital Pharmacies Picture
Figure 11. Retail Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Global Bacterial Vaccines Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Bacterial Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Bacterial Vaccines Revenue Market Share by Region (2017-2028)
Figure 16. Global Bacterial Vaccines Revenue Market Share by Region in 2021
Figure 17. North America Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Bacterial Vaccines Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Bacterial Vaccines Market Drivers
Figure 23. Bacterial Vaccines Market Restraints
Figure 24. Bacterial Vaccines Market Trends
Figure 25. Pfizer Recent Developments and Future Plans
Figure 26. Merck Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. PaxVax Recent Developments and Future Plans
Figure 30. Serum Institute of India Recent Developments and Future Plans
Figure 31. Emergent BioDefense Operations Lansing Recent Developments and Future Plans
Figure 32. Global Bacterial Vaccines Revenue Share by Players in 2021
Figure 33. Bacterial Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Bacterial Vaccines Revenue Market Share in 2021
Figure 35. Global Top 10 Players Bacterial Vaccines Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Bacterial Vaccines Revenue Share by Type in 2021
Figure 38. Global Bacterial Vaccines Market Share Forecast by Type (2023-2028)
Figure 39. Global Bacterial Vaccines Revenue Share by Application in 2021
Figure 40. Global Bacterial Vaccines Market Share Forecast by Application (2023-2028)
Figure 41. North America Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 42. North America Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 43. North America Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 44. United States Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 48. Europe Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 49. Europe Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 50. Germany Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Bacterial Vaccines Revenue Market Share by Region (2017-2028)
Figure 58. China Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 65. South America Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 66. South America Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Bacterial Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Bacterial Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Bacterial Vaccines Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Bacterial Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
